DA32 Life Science Tech Acquisition (DALS) Short Interest Ratio & Short Volume

Short interest is the volume of DA32 Life Science Tech Acquisition shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 1,900 shares of DALS short. 0.01% of DA32 Life Science Tech Acquisition's shares are currently sold short. Learn More on DA32 Life Science Tech Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of DA32 Life Science Tech Acquisition's floating shares are currently sold short.

DA32 Life Science Tech Acquisition saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,900 shares, an increase of 58.3% from the previous total of 1,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

DA32 Life Science Tech Acquisition currently has issued a total of 0 shares. Some of DA32 Life Science Tech Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. DA32 Life Science Tech Acquisition currently has a public float of 20,400,000 shares.

0.01% of DA32 Life Science Tech Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "holding & other investment offices" compare to DA32 Life Science Tech Acquisition: Bain Capital Specialty Finance, Inc. (0.49%), Trinity Capital Inc. (1.80%), Ares Acquisition Co. II (1.27%), CION Investment Co. (1.08%), Nabors Energy Transition Corp. II (0.17%), Marblegate Acquisition Corp. (0.49%), Sound Point Meridian Capital, Inc. (0.04%), Codere Online Luxembourg, S.A. (2.48%), Inflection Point Acquisition Corp. II (0.56%), Cartesian Growth Co. II (0.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks.

Short selling DALS is an investing strategy that aims to generate trading profit from DA32 Life Science Tech Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for DA32 Life Science Tech Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DALS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DALS, twice per month. The most recent reporting period available is July, 15 2023.